Ascendis Pharma A/S (ASND)
214.55
+8.74
(+4.25%)
USD |
NASDAQ |
Jun 09, 15:50
Ascendis Pharma Shareholders Equity (Quarterly) : 562.24M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Evaxion AS | 13.21M |
| DBV Technologies SA | 207.90M |
| Genmab A/S | 5.682B |
| Cellectis SA | 59.92M |
| Akari Therapeutics Plc | 14.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.308B |
| Total Liabilities (Quarterly) | 1.746B |
| Debt to Equity Ratio | 1.838 |
| Current Ratio | 0.9961 |
| Net Debt Paydown Yield | -0.21% |